Athan Kuliopulos

8.3k citations

94 papers · 6.6k indexed · 1 hit paper · h-index 48

Molecular Biology top 2%
Hematology top 0.2%
Cancer Research top 1%
Cardiology and Cardiovascular Medicine top 2%
Genetics top 1%

Co-authors: Lidija Covic Anika Agarwal Andrew J. Leger Suzanne L. Jacques Nicole C. Kaneider Adrienne Boire Amy L. Gresser Katie O’Callaghan
Topics: Blood Coagulation and Thrombosis Mechanisms (37 papers)Protease and Inhibitor Mechanisms (20 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Cell Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States United Kingdom Canada

In The Last Decade

Athan Kuliopulos

94 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells

2005 664 citations Adrienne Boire, Lidija Covic et al. profile →

Peers

Countries citing papers authored by Athan Kuliopulos

Since Specialization

Citations

This map shows the geographic impact of Athan Kuliopulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athan Kuliopulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athan Kuliopulos more than expected).

Fields of papers citing papers by Athan Kuliopulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athan Kuliopulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athan Kuliopulos. The network helps show where Athan Kuliopulos may publish in the future.

Co-authorship network of co-authors of Athan Kuliopulos

This figure shows the co-authorship network connecting the top 25 collaborators of Athan Kuliopulos. A scholar is included among the top collaborators of Athan Kuliopulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athan Kuliopulos. Athan Kuliopulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization 2020 ·Arteriosclerosis Thrombosis and Vascular Biology ·Athan Kuliopulos,Paul A. Gurbel,Jeffrey J. Rade,Carey Kimmelstiel,(unknown),Kevin P. Bliden,Elizabeth K. Fletcher,Daniel H. Cox,Lidija Covic,(unknown)	21
2	PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease 2019 ·Molecular Metabolism ·(unknown),Andrew Shearer,Elizabeth K. Fletcher,Nga Nguyen,(unknown),Daniel H. Cox,Manal F. Abdelmalek,Ying Wang,James Baleja,Lidija Covic,Athan Kuliopulos	27
3	PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models 2018 ·Journal of Investigative Dermatology ·Travis P. Barr,(unknown),(unknown),Elizabeth K. Fletcher,Nga Nguyen,Adam J. Wieschhaus,Lluís Ferrer,Lidija Covic,Athan Kuliopulos	56
4	Tissue Concentrations of Vitamin K and Expression of Key Enzymes of Vitamin K Metabolism Are Influenced by Sex and Diet but Not Housing in C57Bl6 Mice 2016 ·Journal of Nutrition ·Stephanie G. Harshman,Xueyan Fu,J. Philip Karl,Kathryn Barger,Stefania Lamon‐Fava,Athan Kuliopulos,Andrew S. Greenberg,Donald E. Smith,Xiaohua Shen,Sarah L. Booth	22
5	Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics 2015 ·Methods in molecular biology ·Ping Zhang,Lidija Covic,Athan Kuliopulos	27
6	Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2 2015 ·Oncogene ·Eric Yang,Jarosław Cisowski,Nga Nguyen,Katie O’Callaghan,Jian Xu,Anika Agarwal,Athan Kuliopulos,Lidija Covic	43
7	Mouse Matrix Metalloprotease‐1a (Mmp1a) Gives New Insight Into MMP Function 2014 ·Journal of Cellular Physiology ·Caitlin Foley,Athan Kuliopulos	26
8	Selective Blockade of Matrix Metalloprotease-14 with a Monoclonal Antibody Abrogates Invasion, Angiogenesis, and Tumor Growth in Ovarian Cancer 2013 ·Cancer Research ·Rajani Kaimal,Raid Aljumaily,Sarah L. Tressel,(unknown),Lidija Covic,Athan Kuliopulos,Corrine Zarwan,Young B. Kim,Sheida Sharifi,Anika Agarwal	48
9	Noncanonical Matrix Metalloprotease-1-Protease-activated Receptor-1 Signaling Triggers Vascular Smooth Muscle Cell Dedifferentiation and Arterial Stenosis 2013 ·Journal of Biological Chemistry ·Karyn M. Austin,Nga Nguyen,(unknown),Lidija Covic,Athan Kuliopulos	40
10	Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer 2011 ·American Journal Of Pathology ·Jarosław Cisowski,Katie O’Callaghan,Athan Kuliopulos,John Yang,Nga Nguyen,Qing Deng,Eric Yang,Michael Fogel,Sarah L. Tressel,Caitlin Foley,Anika Agarwal,S. Hunt,(unknown),(unknown),Lidija Covic	75
11	Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy 2010 ·Cancer Research ·Anika Agarwal,Sarah L. Tressel,Rajani Kaimal,(unknown),(unknown),Lidija Covic,Athan Kuliopulos	94
12	Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis 2009 ·Cancer Research ·Eric Yang,Adrienne Boire,Anika Agarwal,Nga Nguyen,Katie O’Callaghan,Powen Tu,Athan Kuliopulos,Lidija Covic	121
13	Insider access: pepducin symposium explores a new approach to GPCR modulation 2009 ·Annals of the New York Academy of Sciences ·Jacquelyn Miller,Anika Agarwal,Lakshmi A. Devi,(unknown),James A. Hamilton,Jean‐Philippe Pin,Denis C. Shields,C. Arnold Spek,Thomas P. Sakmar,Athan Kuliopulos,S. Hunt	36
14	Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer 2008 ·Molecular Cancer Therapeutics ·Anika Agarwal,Lidija Covic,Leila M. Sevigny,Nicole C. Kaneider,Katherine Lazarides,Gissou Azabdaftari,Sheida Sharifi,Athan Kuliopulos	86
15	Tumor-Derived Cyr61(CCN1) Promotes Stromal Matrix Metalloproteinase-1 Production and Protease-Activated Receptor 1–Dependent Migration of Breast Cancer Cells 2006 ·Cancer Research ·Nga Nguyen,Athan Kuliopulos,Roger A. Graham,Lidija Covic	66
16	Structural Basis for Thrombin Activation of a Protease-Activated Receptor 2003 ·Chemistry & Biology ·Stacy K. Seeley,Lidija Covic,Suzanne L. Jacques,James L. Sudmeier,James Baleja,Athan Kuliopulos	61
17	NMR studies of the ''on'' and ''off'' states of the human thrombin receptor 1996 ·Blood ·Stacy K. Seeley,James Baleja,Athan Kuliopulos	1
18	Localization of the Factor IX Propeptide Binding Site on Recombinant Vitamin K Dependent Carboxylase Using Benzoylphenylalanine Photoaffinity Peptide Inactivators 1995 ·Biochemistry ·Masahiko Yamada,Athan Kuliopulos,Noele P. Nelson,David A. Roth,Bruce Furie,(unknown),Christopher T. Walsh	40
19	Catalytic mechanism of an active-site mutant (D38N) of .DELTA.5-3-ketosteroid isomerase 1991 ·Biochemistry ·Xue Lin,Athan Kuliopulos,Albert S. Mildvan,Paul Talalay	36
20	Combined effects of two mutations of catalytic residues on the ketosteroid isomerase reaction 1990 ·Biochemistry ·Athan Kuliopulos,Paul Talalay,Albert S. Mildvan	51

About Athan Kuliopulos

Athan Kuliopulos is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 94 papers that have together received 6.6k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (37 papers), Protease and Inhibitor Mechanisms (20 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (957 citations) and Cancer Research (1.3k citations). Athan Kuliopulos has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Lidija Covic, Anika Agarwal, Andrew J. Leger, Suzanne L. Jacques, Nicole C. Kaneider, Adrienne Boire, Amy L. Gresser, Katie O’Callaghan, Paul Talalay and Albert S. Mildvan. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact